Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats (Q48863675)

16 February 2018

title

Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats (English)

1 reference

16 February 2018

author name string

Senda T

1

1 reference

16 February 2018

Matsuno K

2

1 reference

16 February 2018

Okamoto K

3

1 reference

16 February 2018

Kobayashi T

4

1 reference

16 February 2018

Nakata K

5

1 reference

16 February 2018

Mita S

6

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 November 1996

1 reference

16 February 2018

European Journal of Pharmacology

published in

1 reference

16 February 2018

volume

315

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

1-10

1 reference

16 February 2018

Selective memory loss following nucleus basalis lesions: long term behavioral recovery despite persistent cholinergic deficiencies

cites work

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Cholinergic function and intellectual decline in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Sigma receptors: from molecule to man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Scopolamine effects on memory retention in mice: a model of dementia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for ( )-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Selective stimulation of colonic motor response to a meal by sigma ligands in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

JO1784, a novel sigma ligand, potentiates [3H]acetylcholine release from rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Regional differences of the effect of sigma receptor ligands on the acetylcholine release in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Regional variation in the ratio of sigma 1 to sigma 2 binding in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Increase of extracellular acetylcholine level in rat frontal cortex induced by ( )N-allylnormetazocine as measured by brain microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Correlation between potentiation of neurogenic twitch contraction and benzomorphan sigma receptor binding potency in the mouse vas deferens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Ameliorating effects of sigma receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Involvement of sigma 1 receptor in ( )-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Binding properties of SA4503, a novel and selective sigma 1 receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Behavioral evidence for a modulating role of sigma ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

NE-100, a novel sigma receptor ligand: in vivo tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

JO 1784, a potent and selective ligand for rat and mouse brain sigma-sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Influence of N-allyl-normetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Sigma receptors. Putative links between nervous, endocrine and immune systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

Animal models of Alzheimer's disease: experimental cholinergic denervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(96)00572-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(96)00572-9

1 reference

16 February 2018

1 reference

16 February 2018